Clover Health Investments, CORP /DE Form 4 insider transactions

Jamie L. Reynoso, CEO, Medicare Advantage of Clover Health Investments, Corp. /De, sold 1,921 shares of common stock on September 17, 2026 for $4.56 per share.

Joseph Frank Oldakowski, VP OF FINANCE AND CONTROLLER of Clover Health Investments, Corp. /De, sold 3,170 shares of common stock on September 16, 2026 for $4.64 per share.

Conrad Wai, CEO, Counterpart Health of Clover Health Investments, Corp. /De, sold 300,000 shares of common stock on September 15, 2026 for $4.72 per share.

Karen Soares, Chief Legal Officer of Clover Health Investments, Corp. /De, sold 6,846 shares of common stock on September 15, 2026 for $4.78 per share.

Jamie L. Reynoso, CEO, Medicare Advantage of Clover Health Investments, Corp. /De, sold 9,273 shares of common stock on September 15, 2026 for $4.78 per share.

Joseph Frank Oldakowski, VP OF FINANCE AND CONTROLLER of Clover Health Investments, Corp. /De, sold 20,000 shares of common stock on September 14, 2026 for $5.16 per share.

Joseph Clay Thornton, Interim CFO of Clover Health Investments, Corp. /De, sold 17,775 shares of common stock on August 17, 2026 for $4.39 per share.

Karen Soares, Chief Legal Officer of Clover Health Investments, Corp. /De, received 108,695 shares of common stock on August 12, 2026.

Andrew Toy, Chief Executive Officer and a Director of Clover Health Investments, Corp. /De, sold 87,798 shares of common stock on August 10, 2026 for $4.65 per share.

Karen Soares, Chief Legal Officer of Clover Health Investments, Corp. /De, sold 51,700 shares of common stock on July 20, 2026 for $4.51 per share.

Jamie L. Reynoso, CEO, Medicare Advantage of Clover Health Investments, Corp. /De, sold 4,839 shares of common stock on July 17, 2026 for $4.53 per share.

Andrew Toy, Chief Executive Officer and a Director of Clover Health Investments, Corp. /De, sold 62,711 shares of common stock on July 15, 2026 for $4.67 per share.

Conrad Wai, CEO, Counterpart Health of Clover Health Investments, Corp. /De, sold 24,215 shares of common stock on July 15, 2026 for $4.67 per share.

Jamie L. Reynoso, CEO, Medicare Advantage of Clover Health Investments, Corp. /De, sold 13,119 shares of common stock on July 15, 2026 for $4.67 per share.

Karen Soares, Chief Legal Officer of Clover Health Investments, Corp. /De, sold 10,519 shares of common stock on July 15, 2026 for $4.67 per share.

Joseph Clay Thornton, Interim CFO of Clover Health Investments, Corp. /De, sold 4,630 shares of common stock on July 15, 2026 for $4.67 per share.

Clover Health Investments Corp. executive Jamie L. Reynoso reported the sale of 2,384 shares of Class A Common Stock, executed under a pre-arranged Rule 10b5-1 trading plan.

Clover Health Investments Corp. CEO Jamie L. Reynoso sold shares to cover tax obligations related to restricted stock unit vesting.

Clover Health CEO Andrew Toy sold shares to cover tax obligations related to restricted stock unit vesting.

Clover Health Investments Corp. CEO Jamie L. Reynoso sold 2,360 shares of Class A Common Stock for $4.78 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Clover Health Investments Corp. VP of Finance and Controller, Joseph Frank Oldakowski, sold 12,102 shares of Class A Common Stock to cover tax withholding obligations related to restricted stock unit vesting.

Clover Health Investments Corp. Chief Legal Officer Karen Soares sold shares to cover tax obligations related to RSU vesting, a non-discretionary transaction.

Clover Health Investments Corp. officer Jamie L. Reynoso sold shares to cover tax obligations related to RSU vesting, not as a discretionary trade.

Clover Health Investments, Corp. CEO Jamie Reynoso sold 7,289 shares of Class A Common Stock via a 10b5-1 trading plan.

Clover Health CEO Conrad Wai sold 220,426 shares of Class A Common Stock via a pre-arranged Rule 10b5-1 trading plan.

Clover Health Investments, Corp. Director Carladenise Edwards sold 67,160 shares of Class A Common Stock on May 18, 2026.

Clover Health Investments Corp. Interim CFO Joseph Clay Thornton reported a transaction involving the sale of Class A Common Stock to cover tax obligations upon restricted stock unit vesting.

Brady Priest, CEO of Clover Care Services, disposed of 98,039 shares of Clover Health Investments, Corp. at a price of $3.52 per share.

Brady Priest, CEO of Clover Care Services, reported the withholding of 36,113 shares to satisfy tax obligations related to RSU vesting.

Brady Priest, CEO of Clover Care Services, reported the withholding of 15,471 shares to cover tax obligations related to RSU vesting.